Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02756234 · ClinicalTrials.gov registry record

Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting

A clinical trial of Coronary Artery Disease, sponsored by Lancaster General Hospital.

Completed
Registry status
19
Enrollment target
1
Study location

NCT02756234 is a study of Coronary Artery Disease that has completed, run by Lancaster General Hospital. The registered enrollment target is 19 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02756234, a study of Coronary Artery Disease, has completed, sponsored by Lancaster General Hospital.

COMPLETED
Registry status
19 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to carefully monitor all patients undergoing Computed Tomographic Perfusion (CTP) at Lancaster General Hospital for safety, and determine the efficiency of the CTP procedure in a community setting.

Conditions Studied

Study Locations (1)

Pennsylvania

  • Lancaster General Heatlh / Penn Medicine - Lancaster

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2016-05-01
Est. Completion 2018-08-30

Sponsor

Lancaster General Hospital

15 total trials

What the Registry Record Tells You About NCT02756234

The ClinicalTrials.gov registry entry for NCT02756234 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (99% lower). The listed sponsor is Lancaster General Hospital, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT02756234 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02756234 about?

NCT02756234 is a clinical study titled "Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting". The objective of this study is to carefully monitor all patients undergoing Computed Tomographic Perfusion (CTP) at Lancaster General Hospital for safety, and determine the efficiency of the CTP procedure in a community setting.

What is the current status of trial NCT02756234?

This trial is currently completed. The enrollment target is 19 participants. The study started on 2016-05-01. Estimated completion is 2018-08-30.

What conditions does trial NCT02756234 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT02756234?

This trial is sponsored by Lancaster General Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02756234 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.